The Glimepiride Market is witnessing robust growth amid the global rise in diabetes cases and increased accessibility to cost-effective generic treatments. Glimepiride, a widely prescribed oral hypoglycemic agent, remains a key therapy in managing Type 2 diabetes mellitus. With its affordability, efficacy, and favorable safety profile, demand for Glimepiride is surging across emerging and...